Type: | Approved drug |
PubChem: | 5339 |
DrugBank: | DB00795 |
IUPAC: | 2-hydroxy-5-[4-(2-pyridinylsulfamoyl)phenyl]azobenzoic acid |
Standard InChI: | InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25) |
Standard InChIKey: | NCEXYHBECQHGNR-UHFFFAOYSA-N |
SMILES: | O=C(O)C1=CC(N=NC2=CC=C(S(=O)(=O)NC3=CC=CC=N3)C=C2)=CC=C1O |
Metabolism-related information: | Increase activity |
Reference: | 10.1080/03602532.2020.1718691 |
Chemical Structure | Metablite's name | Reaction name | Genus | Species | Reference |
---|---|---|---|---|---|
Sulphapyridine | Reduction | Gut microbiota | Gut microbiota | 10.1016/0378-5173(93)90121-U | |
Mesalamine | Reduction | Gut microbiota | Gut microbiota | 10.1016/0378-5173(93)90121-U |